Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
SurvivorNet on MSN
Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse
The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.
Preliminary safety data from a French registry on combination therapy in immune-mediated inflammatory diseases (IMIDs) show a concerning rate of serious infections and illustrate the need for ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes and CKD had a greater UACR reduction with finerenone plus empagliflozin vs. either ...
Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss and quality of life with combination ixekizumab plus tirzepatide, according to ...
A combination of brexpiprazole (Rexulti) and sertraline improved post-traumatic stress disorder (PTSD) symptoms more than sertraline alone, a phase III trial found. The primary endpoint was the change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results